{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:37Z","timestamp":1786118857648,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/mjt.0b013e31813e65b7","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T03:01:50Z","timestamp":1196737310000},"page":"581-584","source":"Crossref","is-referenced-by-count":15,"title":["Is Acetazolamide Similar to Topiramate for Reversal of Antipsychotic-Induced Weight Gain?"],"prefix":"10.1097","volume":"14","author":[{"given":"Mark E","family":"Schneiderhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Marvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.ijo.0802475","article-title":"Long-term pharmacotherapy for obesity and overweight.","volume":"27","author":"Padwal","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/med.20021","article-title":"Sulfamates and their therapeutic potential.","volume":"25","author":"Winum","year":"2005","journal-title":"Med Res Rev"},{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.","volume":"28","author":"Wilding","year":"2004","journal-title":"Int J Obes"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/oby.2004.206","article-title":"Topiramate: long-term maintenance of weight loss introduced by a low-calorie diet in obese subjects.","volume":"12","author":"Astrup","year":"2004","journal-title":"Obes Res"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2005.03.053","article-title":"Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.","volume":"96","author":"Tonstad","year":"2005","journal-title":"Am J Cardiol"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.","volume":"38","author":"Nickel","year":"2005","journal-title":"Int J Eat Disord"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1053-8119(03)00283-0","article-title":"The effect of acetazolamide on changes of cerebral blood flow and oxygen metabolism during visual stimulation.","volume":"20","author":"Yamauchi","year":"2003","journal-title":"Neuroimage"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/088307380001500805","article-title":"Three children with a syndrome of obesity and overgrowth, atypical psychosis, and seizures: a problem in neuropsychopharmacology.","volume":"15","author":"Jobe","year":"2000","journal-title":"J Child Neurol"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0161-6420(98)91234-9","article-title":"The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumer cerebri).","volume":"105","author":"Johnson","year":"1998","journal-title":"Ophthalmology"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0887-8994(96)00228-7","article-title":"Growth suppression in children receiving acetazolamide with antiepileptic drugs.","volume":"15","author":"Futagi","year":"1996","journal-title":"Ped Neurol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e31813e65b7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:56:03Z","timestamp":1786035363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200711000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31813e65b7","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}